PTPI
Petros Pharmaceuticals
PTPI
PTPI
Delisted
PTPI was delisted on the 21st of May, 2025.
13 hedge funds and large institutions have $558K invested in Petros Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
57% less capital invested
Capital invested by funds: $1.3M → $558K (-$744K)
Holders
13
Holding in Top 10
–
Calls
$12K
Puts
$13K
Top Buyers
| 1 | +$75K | |
| 2 | +$44K | |
| 3 | +$14K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$10.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.61K |
Top Sellers
| 1 | -$205K | |
| 2 | -$162K | |
| 3 | -$115K | |
| 4 |
BlackRock
New York
|
-$22.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8K |